Gac Med Mex
-
Previous analyses on the burden of disease in Mexico identified that injuries differentially affect young people, males and working-age people. ⋯ Injuries generate catastrophic consequences in terms of mortality and disability in Mexico. It is necessary to promote and strengthen programs and policies in order to improve the data system and injury prevention.
-
Musculoskeletal disorders (MSD) affect 1.71 billion people worldwide and are the leading cause of disability. ⋯ From 1990 to 2021, MSDs were the main cause of YLDs in Mexico, with a higher impact on adults and women. MSDs can appear early in life, hence the need for continuous interventions in order to preserve quality of life.
-
Chronic kidney disease (CKD) represents a substantial global burden of disease due to a lack of universal tests and misinterpretation of biomarkers. ⋯ CKD in Mexico entails a high burden of mortality and years of life lost, but it barely contributes to disability. It is essential to improve CKD early detection, access to treatments and coding of the causes of the disease. Moreover, investigating the causes of CKD of unknown etiology, including genetic factors, is crucial in order for specific treatments to be developed in the future.
-
Respiratory diseases (RD) are often analyzed separately rather than collectively, possibly leading to an underestimation of their total burden. ⋯ The significant burden of mortality and disability due to RDs in Mexico underscores the n|ecessity for enhanced prevention, research, and for addressing risk factors such as smoking and pollution. Ongoing healthcare training can help reduce RD burden.
-
The information on functional decline after hospitalization for COVID-19 is limited in older adults (OAs). ⋯ COVID-19 infection did not only represent a disease with a high risk of mortality during the acute phase, but is also associated with a high risk of functional impairment after hospital discharge.